Trial intelligence / Profile preview

Simvastatin for Refractory Chronic Rhinosinusitis

NCT01771198Phase 2Terminated

Sponsor
Centre hospitalier de l’Université de Montréal
Start
Aug 2012
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of simvastatin in chronic rhinosinusitis (CRS), sponsored by Centre hospitalier de l’Université de Montréal. Started Aug 2012; status: terminated.

02

Drugs

simvastatin
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on NCT01771198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01771198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call